₹1,000 cr to ₹5,000 cr: 3 pharma stocks to watch for India’s GLP-1 explosion by 2030 – Stock Insights News
The Indian market for Glucagon-Like Peptide-1 (GLP-1) therapies is currently at an inflection point and is poised for strong expansion.…
Smart Investing. Clear Insights.
The Indian market for Glucagon-Like Peptide-1 (GLP-1) therapies is currently at an inflection point and is poised for strong expansion.…
Stock markets are full of surprises. And this is revealed in full colour in this report as well. Let’s start…
The National Highways Authority of India (NHAI) has raised Rs 28,307 crore from monetisation this financial year with the last…
As we step into the new financial year, corporate India will see some major action unfold. Major firms like TVS…
Brokerage consensus buy calls: At least 6 brokerages, Nomura, Motilal Oswal, JM Financial, Nuvama, Axis Securities, and Jefferies have collectively…
The Metal Sector Anomaly: Why Value Stocks are Mispriced As the metal manufacturing industry giants bask in the spotlight of…
On February 27th, a day before the West Asia conflict began, gold traded at $5,278. One month later, as of…
Indians are travelling more than ever before. The numbers clearly show this shift. According to a report by the Ministry…
Rentomojo, the online rental and subscription platform for home furniture and appliances, has filed its Draft Red Herring Prospectus (DRHP)…
Gold started 2026 on a strong bullish undertone following a 65% return last year, but has since struggled to maintain…